Susquehanna International Group (Ireland)’s AbbVie ABBV Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$448K	Buy	+2,267	New	+$423K	0.09%	63

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Susquehanna International Group (Ireland)'s ABBV Position: Q3 2024 in Review

Susquehanna International Group (Ireland) opened a new position in AbbVie (ABBV) in Q3 2024: 2,267 shares worth $448K. The stake represents 0.09% of the portfolio and ranks #63 among its holdings.

3,504 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Susquehanna International Group (Ireland) held 2,267 shares of AbbVie worth $448K as of Q3 2024.
AbbVie was a new Susquehanna International Group (Ireland) position in Q3 2024.
AbbVie made up 0.09% of Susquehanna International Group (Ireland)'s portfolio in Q3 2024, its #63 holding.
3,504 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2024, filed 14 Nov 2024.